Targetry of SrCO3 on a copper substrate by sedimentation method for the cyclotron production no-carrier-added 86Y

86Y-DOTA0-d-Phe1-Tyr3-octreotide (SMT487)—a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion

François Jamar, Raffaella Barone, Isabelle Mathieu et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2003 · 240 citations

Pharmacy, Pharmacokinetics, Pharmacology +8

Pre-therapeutic dosimetry and biodistribution of 86Y-DOTA-Phe1-Tyr3-octreotide versus 111In-pentetreotide in patients with advanced neuroendocrine tumours

Andreas Helisch, GregorJ. F�rster, Helmut Reber et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2004 · 130 citations

Medicine, Nuclear Medicine, Pharmacokinetics +14

A new and convenient method for purification of 86Y using a Sr(II) selective resin and comparison of biodistribution of 86Y and 111In labeled Herceptin™

Kayhan Garmestani, Diane E. Milenic, Paul S. Plascjak et al. · Nuclear Medicine and Biology · 2002 · 126 citations

Pharmacy, Biochemistry, Pharmaceutics +10

Nuclear Data Relevant to the Production of the Positron Emitting Radioisotope ⁸⁶Y via the ⁸⁶Sr(p,n)- and ^natRb(³He,xn)-Processes

Frank Rösch, S.M. Qaim, G. Stöcklin · Radiochimica Acta · 1993 · 117 citations

Natural Sciences, Physics, Nuclear Chemistry +8

Production of the positron emitting radioisotope 86Y for nuclear medical application

Frank Rösch, S.M. Qaim, G. Stöcklin · Applied Radiation and Isotopes · 1993 · 92 citations

Natural Sciences, Nuclear Medicine, Radiology +12